Back
Impact Shares NAACP Minority Empwrmt ETF Vs. Halozyme Therapeutics Industry Stock Comparison
Sell
50
NACP
Impact Shares NAACP Minority Empwrmt ETF
Last Price:
42.07
Seasonality Move:
4.59%
Sell
39
HALO
Halozyme Therapeutics
Last Price:
45.65
Seasonality Move:
17.03%
Sell
50
Impact Shares NAACP Minority Empwrmt ETF (NACP)
is a Sell
Is Impact Shares NAACP Minority Empwrmt ETF a Buy, Sell or Hold?
- The current Impact Shares NAACP Minority Empwrmt ETF [NACP] share price is $42.10. The Score for NACP is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
- NACP is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Halozyme Therapeutics (HALO)
is a Sell
Is Halozyme Therapeutics a Buy, Sell or Hold?
- The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
- HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
NACP Stock Price Chart
What is Impact Shares NAACP Minority Empwrmt ETF's stock price today?
-
The Impact Shares NAACP Minority Empwrmt ETF share price today is $42.10
The current trend is moderately bearish and NACP is experiencing slight selling pressure.
HALO Stock Price Chart
What is Halozyme Therapeutics's stock price today?
-
The Halozyme Therapeutics share price today is $45.65
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.
NACP Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.35 | Buy |
Relative Strength Index (14 RSI): | 51.48 | Buy |
Chaikin Money Flow: | -1908 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (41.45 - 42.69) | Buy |
Bollinger Bands (100): | (39.17 - 41.77) | Buy |
HALO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.02 | Sell |
Relative Strength Index (14 RSI): | 30.2 | Sell |
Chaikin Money Flow: | -7140517 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (49.94 - 58.56) | Sell |
Bollinger Bands (100): | (52.16 - 60.38) | Sell |
NACP Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 42.78 | Sell |
20-day SMA: | 42.05 | Buy |
50-day SMA: | 41.45 | Buy |
200-day SMA: | 39.11 | Buy |
8-day EMA: | 42.48 | Sell |
20-day EMA: | 42.17 | Sell |
50-day EMA: | 41.49 | Buy |
200-day EMA: | 38.92 | Buy |
HALO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 57.53 | Sell |
20-day SMA: | 54.48 | Sell |
50-day SMA: | 56.18 | Sell |
200-day SMA: | 48.93 | Sell |
8-day EMA: | 55 | Sell |
20-day EMA: | 55.41 | Sell |
50-day EMA: | 55.64 | Sell |
200-day EMA: | 50.73 | Sell |
Impact Shares NAACP Minority Empwrmt ETF Earnings Growth & NACP Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Halozyme Therapeutics Earnings Growth & HALO Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.30 per share, and an increase next year of $0.71 per share.
Impact Shares NAACP Minority Empwrmt ETF Technical Analysis
Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Halozyme Therapeutics Technical Analysis
Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |